Invatec's drug-eluting balloon, IN.PACT Amphirion, has been shown to reduce restenosis by more than 50% when used to treat critical limb ischaemia (CLI) below the knee. Without treatment, around 69% of CLI patients with long lesions show restenosis after three months. Preliminary results from the ...
Please Login to read the full article.
